Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

Nikolaus Marx; Dirk Müller-Wieland; Christine Espinola-Klein; Martin Halle; Annette Birkenhagen; Patrick Diemert; Felix Mahfoud; Harm Wienbergen; Katharina Schütt

doi:10.1007/s12181-024-00689-6

Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

Nikolaus Marx, Dirk Müller-Wieland, Christine Espinola-Klein, Martin Halle, Annette Birkenhagen, Patrick Diemert, Felix Mahfoud, Harm Wienbergen, Katharina Schütt

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Abstract

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

Titel in Übersetzung	Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes
Originalsprache	Deutsch
Seiten (von - bis)	256-265
Seitenumfang	10
Fachzeitschrift	Kardiologie
Jahrgang	18
Ausgabenummer	3
DOIs	https://doi.org/10.1007/s12181-024-00689-6
Publikationsstatus	Veröffentlicht - Juni 2024
Extern publiziert	Ja

Schlagwörter

Cardiovascular disease
Diabetes mellitus
Heart failure
Kidney failure

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1007/s12181-024-00689-6

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{eeedfff667ab4bcbbaf9305f872e98ac,

title = "Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskul{\"a}rer Erkrankungen bei Patienten mit Diabetes",

abstract = "Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.",

keywords = "Cardiovascular disease, Diabetes mellitus, Heart failure, Kidney failure",

author = "Nikolaus Marx and Dirk M{\"u}ller-Wieland and Christine Espinola-Klein and Martin Halle and Annette Birkenhagen and Patrick Diemert and Felix Mahfoud and Harm Wienbergen and Katharina Sch{\"u}tt",

note = "Publisher Copyright: {\textcopyright} Deutsche Gesellschaft f{\"u}r Kardiologie - Herz- und Kreislaufforschung e.V. Published by Springer Medizin Verlag GmbH, ein Teil von Springer Nature - all rights reserved 2024.",

year = "2024",

month = jun,

doi = "10.1007/s12181-024-00689-6",

language = "Deutsch",

volume = "18",

pages = "256--265",

journal = "Kardiologie",

issn = "2731-7129",

publisher = "Springer Medizin",

number = "3",

}

TY - JOUR

T1 - Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

AU - Marx, Nikolaus

AU - Müller-Wieland, Dirk

AU - Espinola-Klein, Christine

AU - Halle, Martin

AU - Birkenhagen, Annette

AU - Diemert, Patrick

AU - Mahfoud, Felix

AU - Wienbergen, Harm

AU - Schütt, Katharina

N1 - Publisher Copyright: © Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung e.V. Published by Springer Medizin Verlag GmbH, ein Teil von Springer Nature - all rights reserved 2024.

PY - 2024/6

Y1 - 2024/6

N2 - Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

AB - Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

KW - Cardiovascular disease

KW - Diabetes mellitus

KW - Heart failure

KW - Kidney failure

UR - http://www.scopus.com/inward/record.url?scp=85193329968&partnerID=8YFLogxK

U2 - 10.1007/s12181-024-00689-6

DO - 10.1007/s12181-024-00689-6

M3 - Artikel

AN - SCOPUS:85193329968

SN - 2731-7129

VL - 18

SP - 256

EP - 265

JO - Kardiologie

JF - Kardiologie

IS - 3

ER -

Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

Abstract

Schlagwörter

UN SDGs

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Dieses zitieren